List of Excipients in API alectinib hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing alectinib hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Genentech Inc | ALECENSA | alectinib hydrochloride | 50242-130 | CARBOXYMETHYLCELLULOSE CALCIUM | 2035-04-24 |
| Genentech Inc | ALECENSA | alectinib hydrochloride | 50242-130 | CARNAUBA WAX | 2035-04-24 |
| Genentech Inc | ALECENSA | alectinib hydrochloride | 50242-130 | CARRAGEENAN | 2035-04-24 |
| Genentech Inc | ALECENSA | alectinib hydrochloride | 50242-130 | FD&C BLUE NO. 2 | 2035-04-24 |
| Genentech Inc | ALECENSA | alectinib hydrochloride | 50242-130 | FERRIC OXIDE RED | 2035-04-24 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for alectinib hydrochloride
Excipient focus: CARBOXYMETHYLCELLULOSE CALCIUM
alectinib hydrochloride drug variants containing CARBOXYMETHYLCELLULOSE CALCIUM
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | alectinib hydrochloride | 50242-130 |
| >Company | >Ingredient | >NDC |
alectinib hydrochloride drug variants not containing CARBOXYMETHYLCELLULOSE CALCIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARNAUBA WAX
alectinib hydrochloride drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | alectinib hydrochloride | 50242-130 |
| >Company | >Ingredient | >NDC |
alectinib hydrochloride drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARRAGEENAN
alectinib hydrochloride drug variants containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | alectinib hydrochloride | 50242-130 |
| >Company | >Ingredient | >NDC |
alectinib hydrochloride drug variants not containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
alectinib hydrochloride drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | alectinib hydrochloride | 50242-130 |
| >Company | >Ingredient | >NDC |
alectinib hydrochloride drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
alectinib hydrochloride drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | alectinib hydrochloride | 50242-130 |
| >Company | >Ingredient | >NDC |
alectinib hydrochloride drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
alectinib hydrochloride drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | alectinib hydrochloride | 50242-130 |
| >Company | >Ingredient | >NDC |
alectinib hydrochloride drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL OLEATE
alectinib hydrochloride drug variants containing GLYCERYL OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | alectinib hydrochloride | 50242-130 |
| >Company | >Ingredient | >NDC |
alectinib hydrochloride drug variants not containing GLYCERYL OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
alectinib hydrochloride drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | alectinib hydrochloride | 50242-130 |
| >Company | >Ingredient | >NDC |
alectinib hydrochloride drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
alectinib hydrochloride drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | alectinib hydrochloride | 50242-130 |
| >Company | >Ingredient | >NDC |
alectinib hydrochloride drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
alectinib hydrochloride drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | alectinib hydrochloride | 50242-130 |
| >Company | >Ingredient | >NDC |
alectinib hydrochloride drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
alectinib hydrochloride drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | alectinib hydrochloride | 50242-130 |
| >Company | >Ingredient | >NDC |
alectinib hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CHLORIDE
alectinib hydrochloride drug variants containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | alectinib hydrochloride | 50242-130 |
| >Company | >Ingredient | >NDC |
alectinib hydrochloride drug variants not containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
alectinib hydrochloride drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | alectinib hydrochloride | 50242-130 |
| >Company | >Ingredient | >NDC |
alectinib hydrochloride drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
alectinib hydrochloride drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | alectinib hydrochloride | 50242-130 |
| >Company | >Ingredient | >NDC |
alectinib hydrochloride drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
alectinib hydrochloride drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | alectinib hydrochloride | 50242-130 |
| >Company | >Ingredient | >NDC |
alectinib hydrochloride drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
alectinib hydrochloride drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | alectinib hydrochloride | 50242-130 |
| >Company | >Ingredient | >NDC |
alectinib hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links